Balancing the outcomes: reporting adverse events
- 16 August 2004
- journal article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 181 (4), 215-218
- https://doi.org/10.5694/j.1326-5377.2004.tb06241.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Noninvasive Positive-Pressure Ventilation for Respiratory Failure after ExtubationThe New England Journal of Medicine, 2004
- Adverse event reporting in clinical trials: room for improvementThe Medical Journal of Australia, 2003
- Patient reporting of potential adverse drug reactions: a methodological studyBritish Journal of Clinical Pharmacology, 2002
- Survey of Modalities of Toxicity Assessment and Reporting in Noncomparative Prospective Studies of Chemotherapy in Breast CancerJournal of Clinical Oncology, 2002
- The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2001
- Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trialsBMC Medical Research Methodology, 2001
- The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and ElaborationAnnals of Internal Medicine, 2001
- Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trialThe Lancet, 2001
- Reporting of Adverse Effects in Clinical Trials Should Be Improved: Lessons from Acute Postoperative PainJournal of Pain and Symptom Management, 1999
- Reporting of safety data from randomised trialsThe Lancet, 1998